These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2894399)

  • 1. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants.
    Anderson EL; Belshe RB; Bartram J
    J Infect Dis; 1988 Apr; 157(4):731-7. PubMed ID: 2894399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study comparing an acellular pertussis-component DTP vaccine with a whole-cell pertussis-component DTP vaccine in 18-month-old children.
    Lewis K; Cherry JD; Holroyd HJ; Baker LR; Dudenhoeffer FE; Robinson RG
    Am J Dis Child; 1986 Sep; 140(9):872-6. PubMed ID: 2874738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
    Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
    Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
    Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
    Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study.
    Englund JA; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Anderson EL
    Pediatrics; 1994 Jan; 93(1):37-43. PubMed ID: 8265321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.
    Marcinak JF; Ward M; Frank AL; Boyer KM; Froeschle JE; Hosbach PH
    Am J Dis Child; 1993 Mar; 147(3):290-4. PubMed ID: 8438810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and serologic responses to acellular pertussis vaccine in infants and young children.
    Anderson EL; Belshe RB; Bartram J; Gurwith M; Hung P; Levner M; Vernon SK
    Am J Dis Child; 1987 Sep; 141(9):949-53. PubMed ID: 3618569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.
    Morgan CM; Blumberg DA; Cherry JD; Reisinger KS; Blatter MM; Blumer JL; Dekker CL; Stout MG; Christenson PD
    Am J Dis Child; 1990 Jan; 144(1):41-5. PubMed ID: 2403747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15-24 months and 4-6 years of age. Acellular Pertussis Vaccine Study Team.
    Auerbach BS; Wilson ME; Lake AM; Deforest A; Steinhoff M; Halsey NA
    Vaccine; 1992; 10(1):14-20. PubMed ID: 1539456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule.
    Barkin RM; Samuelson JS; Gotlin LP
    Dev Biol Stand; 1985; 61():297-307. PubMed ID: 2872117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccines in infants: evaluation of single component and two-component products.
    Anderson EL; Mink CM; Berlin BS; Shih CN; Tung FF; Belshe RB
    Vaccine; 1994 Jan; 12(1):28-31. PubMed ID: 8303937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
    Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
    J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.
    Huang LM; Lee CY; Lin TY; Chen JM; Lee PI; Hsu CY
    Vaccine; 1996 Jun; 14(9):916-22. PubMed ID: 8843635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine.
    Murphy MD; Rasnack J; Dickson HD; Dietch M; Brunell PA
    Pediatrics; 1983 Feb; 71(2):200-5. PubMed ID: 6296755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.
    Blumberg DA; Mink CM; Cherry JD; Reisinger KS; Blatter MM; Congeni BL; Dekker CL; Stout MG; Mezzatesta JR; Scott JV
    J Pediatr; 1990 Jul; 117(1 Pt 1):46-51. PubMed ID: 2196360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open study evaluating the reactogenicity and immunogenicity of a DTP vaccine containing an acellular pertussis component in four to six year old children.
    Lewis K; Cherry JD; Baraff LJ; Robinson RG; Dudenhoeffer FE; Holroyd HJ; Baker LR; Farchione SL; Gurwith M; Vernon S
    Dev Biol Stand; 1985; 61():563-9. PubMed ID: 2872132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.
    Bernstein HH; Rothstein EP; Pichichero ME; Francis AB; Kovel AJ; Disney FA; Green JL; Marsocci SM; Lynd AM; Wood GC
    Am J Dis Child; 1992 May; 146(5):556-9. PubMed ID: 1621656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.